Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,146,712
-
Share change
-
+283,860
-
Total reported value
-
$260,885,685
-
Put/Call ratio
-
77%
-
Price per share
-
$10.85
-
Number of holders
-
67
-
Value change
-
+$3,080,000
-
Number of buys
-
2
Institutional Holders of Arrowhead Pharma Inc - COM (ARWR) as of Q4 2013
As of 31 Dec 2013,
Arrowhead Pharma Inc - COM (ARWR) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,146,712 shares.
The largest 10 holders included
MARXE AUSTIN W & GREENHOUSE DAVID M, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, QVT Financial LP, SAC Capital Advisors LP, Camber Capital Management LLC, FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.